Loading clinical trials...
Loading clinical trials...
Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction?
Conditions
Locations
1
United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Start Date
October 1, 2013
Primary Completion Date
October 1, 2014
Completion Date
June 1, 2021
Last Updated
July 2, 2021
NCT06744322
NCT07444957
NCT06788275
NCT07436429
NCT05292404
NCT06118281
Lead Sponsor
Medstar Health Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions